Master the CAMLPR Transfusion Test with interactive questions and detailed explanations. Boost your knowledge and ensure you're exam-ready with comprehensive study resources!

Multiple Choice

When is antibody identification particularly important?

Antibody identification is especially important when there are known antibodies or prior transfusions because exposure to non-self red cell antigens during transfusion can prompt the immune system to form alloantibodies. If those antibodies are present, transfusing cells carrying the corresponding antigens can trigger hemolytic reactions, either immediately or after a delay. Identifying the specific antibody allows the lab to select antigen-negative donor units (for example, avoiding Kell or Duffy antigens if those antibodies are present) and to tailor the crossmatch accordingly, reducing the risk of a transfusion reaction. In a patient with no known antibodies, the immediate risk from alloantibodies is lower, so while screening for antibodies may still occur, the necessity for detailed antibody identification is not as pressing. ABO typing remains essential, but it does not address antibodies against other red cell antigens. This need for antibody identification is not limited to pediatric patients; anyone with a history of transfusion or pregnancy across any age group can develop alloantibodies, making identification crucial in those scenarios.

Antibody identification is especially important when there are known antibodies or prior transfusions because exposure to non-self red cell antigens during transfusion can prompt the immune system to form alloantibodies. If those antibodies are present, transfusing cells carrying the corresponding antigens can trigger hemolytic reactions, either immediately or after a delay. Identifying the specific antibody allows the lab to select antigen-negative donor units (for example, avoiding Kell or Duffy antigens if those antibodies are present) and to tailor the crossmatch accordingly, reducing the risk of a transfusion reaction.

In a patient with no known antibodies, the immediate risk from alloantibodies is lower, so while screening for antibodies may still occur, the necessity for detailed antibody identification is not as pressing. ABO typing remains essential, but it does not address antibodies against other red cell antigens. This need for antibody identification is not limited to pediatric patients; anyone with a history of transfusion or pregnancy across any age group can develop alloantibodies, making identification crucial in those scenarios.